In the process of exploring cellular energy conversion, succinate dehydrogenase (SDH) is undoubtedly a key role that cannot be ignored. Whether in bacteria or human cells, this enzyme complex is not only involved in the chemical reactions of the citric acid cycle, but also plays an important role in the oxidative phosphorylation process. This also makes SDH the only enzyme that is simultaneously involved in these two core biochemical pathways, thus starting the wonderful journey of cellular energy production.
Succinate dehydrogenase is key in energy conversion processes, both through the generation of adenosine triphosphate (ATP) and in maintaining redox balance within cells.
SDH is composed of four structurally different subunits, two of which are hydrophilic and two are hydrophobic. The interaction of these four subunits not only ensures the catalytic function of the enzyme but also facilitates its embedding in the cell membrane. The SDHA subunit contains a covalently linked flavin adenine dinucleotide (FAD) cofactor, which enables it to efficiently drive the oxidation of succinate and transfer the released electrons to a molecule called ubiquinone. (ubiquinone) molecules, ultimately generating reduced ubiquinone (ubiquinol).
This process is actually a perfect example of how SDH plays a two-in-one role in cellular energy production: on the one hand, it participates in the citric acid cycle, and on the other hand, it drives the synthesis of ATP through the electron transport chain.
In the sixth step of the citric acid cycle, succinate is oxidized to fumarate with the simultaneous reduction of ubiquinone. This reaction involves the transfer of electrons and the exchange of protons. The data showed that certain amino acid residues in the SDHA subunit, such as Arg-286, played a role in proton transport. The success of this process depends on a structure containing multiple Fe-S clusters, which facilitate the efficient transfer of electrons.
The oxidation reaction of succinate not only ensures the supply of energy, but also serves as one of the bases for multiple signal transduction within cells, emphasizing the importance of SDH in cell function.
Like many important biochemical enzymes, SDH is also affected by various inhibitors. These inhibitors can be divided into two categories: those that bind to succinate and those that bind to ubiquinone. For example, the compound malonate is a synthetic compound that effectively inhibits SDH activity, an effect that some studies have suggested may help prevent the development of certain types of tumors.
Understanding the mechanisms of these inhibitors could help develop new treatments to combat a variety of diseases caused by abnormal SDH, including certain tumors and other metabolic disorders.
With a better understanding of succinate dehydrogenase, will we be able to find innovative ways to tackle the various diseases related to its activity in the future?